Enterochromaffin cell hyperplasia in irritable pouch syndrome

American Journal of Gastroenterology

Volumn 103, Issue 9, 2008, Pages 2293-2300

  Shen, Bo ^a   Liu, Wendy ^a   Remzi, Feza H ^a   Shao, Zhuo ^a   Lu, Hong ^a   DeLaMotte, Carol ^a   Hammel, Jeffrey ^a   Queener, Elaine ^a   Bambrick, Marlene L ^a   Fazio, Victor W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; SEROTONIN; TRYPTASE;

ADULT; ARTICLE; CELL HYPERPLASIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENTEROCHROMAFFIN CELL; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IRRITABLE POUCH SYNDROME; LYMPHOCYTE; MALE; MAST CELL; MUCOSA CELL; MUCOSA INFLAMMATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POUCHITIS DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANASTOMOSIS, SURGICAL; BIOPSY; CHI-SQUARE DISTRIBUTION; ENTEROCHROMAFFIN CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 50649084795     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01990.x     Document Type: Article

References (52)

1. Shen B, Achkar J-P, Lashner BA, et al. Irritable pouch syndrome: A new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002 97 : 972 7.
2. Shen B, Sanmiguel C, Parsi M, et al. Irritable pouch syndrome (IPS) is characterized by visceral hypersensitivity and poor quality of life (QOL) score. Gastroenterology 2004 126 (Suppl 2) : A124.
3. Shen B, Fazio VW, Remzi FH, et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2006 4 : 81 9.
4. Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol 2006 19 : 1638 45.
5. Shen B, Lashner BA, Achkar J-P, et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003 46 : 748 53.
6. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol 2005 100 : 93 101.
7. Shen B, Fazio VW, Remzi FH, et al. Risk factors for clinical phenotypes of Crohn's disease of the pouch. Am J Gastroenterol 2006 101 : 2760 8.
8. Shen B, Lashner BA, Bennett AE, et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004 99 : 1527 31.
9. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: A Pouchitis Disease Activity Index. Mayo Clin Proc 1994 69 : 409 15.
10. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in post-infectious IBS. Gastroenterology 2003 125 : 1651 9.
11. Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005 3 : 349 57.
12. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002 122 : 1778 83.
13. Wood JD. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Gut 2006 55 : 445 7.
14. Chun A, Desautels S, Slivka A, et al. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of Oddi dysfunction, type III. Dig Dis Sci 1999 44 : 631 6.
15. Simrén M, Castedal M, Svedlund J, et al. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Dig Dis Sci 2000 45 : 2151 61.
16. Evans PR, Kellow JE. Physiological modulation of jejunal sensitivity in health and in irritable bowel syndrome. Am J Gastroenterol 1998 93 : 2191 6.
17. Bayless TM. Coexistent irritable bowel syndrome and inflammatory bowel disease. In : Bayless TM, Hanauer SB, eds. Advanced therapy of inflammatory bowel disease, 1st Ed. Hamilton, Ontario : B.C. Decker, 2001 : 91 4.
18. Schiller LR. Diarrhea following small bowel resection. In : Bayless TM, Hanauer SB, eds. Advanced therapy of inflammatory bowel disease. 1st Ed, Hamilton, Ontorio : B.C. Decker, 2001 : 471 4.
19. Isgar B, Hartman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983 24 : 190 2.
20. Rao SSC, Read NW, Brown C, et al. Studies on the mechanism of bowel disturbance in ulcerative colitis. Gastroenterology 1987 93 : 934 40.
21. Miller R, Orrom WJ, Duthie G, et al. Ambulatory anorectal physiology in patients following restorative proctocolectomy for ulcerative colitis: Comparison with normal controls. Br J Surg 1990 77 : 895 7.
22. Bernstein CN, Rollandilli R, Niazi N, et al. Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol 1997 92 : 103 8.
23. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002 122 : 1771 7.
24. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission: Relationships with quality of life and coping behavior. Dig Dis Sci 2004 49 : 469 74.
25. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002 97 : 389 96.
26. Snape WJ, Carlson GM, Cohen S. Colonic myoelectric activity in the irritable colon syndrome. Gastroenterology 1976 70 : 236 30.
27. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990 99 : 1688 704.
28. Harvey RF, Read AE. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome. Lancet 1973 1 : 1 3.
29. Whitehead WE, Crowel MD. Psychologic considerations in the irritable bowel syndrome. Gastroenterol Clin North Am 1991 20 : 249 67.
30. Schwarz SP, Blanchard EB, Berreman CF, et al. Psychological aspects of irritable bowel syndrome: Comparisons with inflammatory bowel disease and nonpatient controls. Behav Res Ther 1993 31 : 297 304.
31. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Ann Intern Med 2000 133 : 136 47.
32. Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain. Molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: A source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 2000 278 G670 6.
33. Bradette M, Delvaux M, Staumont G, et al. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci 1994 39 : 449 57.
34. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997 42 : 223 41.
35. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 109 : 40 52.
36. Barbara G, Stanghellini V, De Giorgio R, et al. Functional gastrointestinal disorders and mast cells: Implications for therapy. Neurogastroenterol Motil 2006 18 : 6 17.
37. Barbara G, Wang B, Stanghellini V, et al. Mast cell- dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007 132 : 26 37.
38. Tunc B, Filik L, Altintas E, et al. Mucosal mast cells in irritable bowel syndrome and inflammatory bowel disease. Acta Medica (Hradec Kralove) 2005 48 : 163 4.
39. Weston AP, Biddle WL, Bhatia PS, et al. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993 38 : 1590 5.
40. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007 56 : 203 9.
41. Santos J, Guilarte M, Alonso C, et al. Pathogenesis of irritable bowel syndrome: The mast cell connection. Scand J Gastroenterol 2005 40 : 129 40.
42. Park JH, Rhee PL, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol 2006 21 : 71 8.
43. Wade PR, Chen J, Jaffe B, et al. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996 16 : 2352 64.
44. El Salhy M, Danielsson A, Stenling R, et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997 242 : 413 9.
45. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004 126 : 1657 64.
46. Minderhoud IM, Oldenburg B, Schipper ME, et al. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 2007 5 : 714 20.
47. Camilleri M, Andrews CN, Bharucha AE, et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007 132 : 17 25.
48. Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005 17 : 863 70.
49. Brittan M, Wright NA. Gastrointestinal stem cells. J Pathol 2002 197 : 492 509.
50. Mawe GM, Coates MD, Moses PL. Review article: Intestinal serotonin signaling in irritable bowel syndrome. Aliment Pharmacol Ther 2006 23 : 1067 76.
51. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 20.
52. Schmidt C, Hauser W, Giese T, et al. Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts. Inflamm Bowel Dis 2007 13 : 1502 8.